Why Don’t We Have Proven Treatments for HFpEF?
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
T he lack of effective treatments for heart failure with preserved ejection fraction represents a large and growing unmet need in cardiology today.A critical obstacle to therapeutic innovation in heart failure with preserved ejection fraction has been the absence of animal models that accurately recapitulate the complexities of the human disease.Here, we propose that more comprehensive multiorgan system and functional phenotyping of preclinical models is essential if we are to maximize our chances of discovering and validating novel targets for effective therapeutic development in heart failure with preserved ejection fraction.Why Don't We Have Proven Treatments for HFpEF?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathophysiology of heart failure with preserved ejection fraction
Borlaug, B. A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.83 · Cited by 726 · cited 1×
“These involve not only diastolic function but also cardiac reserves, systemic and pulmonary vascular function, renal function, oxygen carrying capacity, and peripheral oxygen extraction.(3) Complicating matters further, the degree to which each of these systems is altered, and hence, the relative impact of each one on…”
BackgroundZile, M. R., Gottdiener, J. S., Hetzel, S. J., McMurray, J. J., Komajda, M., McKelvie, R., Baicu, C. F., Massie, B. M., & Carson, P. E. (2011) · Circulation · doi:10.1161/circulationaha.110.011031 · Cited by 517 · cited 8×
“In the United States, the prevalence of HFpEF, relative to heart failure with reduced ejection fraction (HFrEF), is increasing at an alarming rate of 1%/y with the overwhelming majority of patients being >65 years.2 Importantly, the prognosis for HFpEF remains poor with mortality rates comparable with HFrEF.2 Unfortun…”
BackgroundInfluential
Cited by
Nitrosative stress drives heart failure with preserved ejection fraction
Schiattarella, G. G., Altamirano, F., Tong, D., French, K. M., Villalobos, E., Kim, S. Y., Luo, X., Jiang, N., May, H. I., Wang, Z. V., et al. (2019) · Nature · doi:10.1038/s41586-019-1100-z · Cited by 951
Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF
Deng, Y., Xie, M., Li, Q., Xu, X., Ou, W., Zhang, Y., Xiao, H., Yu, H., Zheng, Y., Liang, Y., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317933 · Cited by 409
Metabolic inflammation in heart failure with preserved ejection fraction
Schiattarella, G. G., Rodolico, D., & Hill, J. A. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa217 · Cited by 284
Withaar, C., Lam, C. S. P., Schiattarella, G. G., de Boer, R. A., & Meems, L. M. G. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab389 · Cited by 150
The role of diet and nutrition in heart failure: A state-of-the-art narrative review
Billingsley, H. E., Hummel, S. L., & Carbone, S. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.08.004 · Cited by 106
Metadata
- Authors
- Roh, J., Houstis, N., & Rosenzweig, A.
- Venue
- Circulation Research
- Published
- 2017-04-14
- Volume
- 120
- Issue
- 8
- Pages
- 1243-1245
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2605576636
- Cited by
- 106
- References
- 2
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Why Don’t We Have Proven Treatments for HFpEF? https://app.cochat.ai/papers/10.1161/circresaha.116.310119
- The paper
- Roh, J., Houstis, N., & Rosenzweig, A. (2017). Why Don’t We Have Proven Treatments for HFpEF? Circulation Research. https://doi.org/10.1161/circresaha.116.310119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.